BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34957894)

  • 1. Angioimmunoblastic T-cell lymphoma: treatment strategies and prognostic factors from a retrospective multicenter study in China.
    Zhang C; Mi L; Wu M; Liu W; Ma H; Ren J; Zhao L; Wang X; Song Y; Zhu J
    Leuk Lymphoma; 2022 May; 63(5):1152-1159. PubMed ID: 34957894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive comparison of international prognostic indexes for follicular helper T-cell lymphoma.
    Lee YP; Yoon SE; Cho J; Ko YH; Jo H; Kim SJ; Kim WS
    Ann Hematol; 2022 Jul; 101(7):1535-1543. PubMed ID: 35639152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell Project.
    Advani RH; Skrypets T; Civallero M; Spinner MA; Manni M; Kim WS; Shustov AR; Horwitz SM; Hitz F; Cabrera ME; Dlouhy I; Vassallo J; Pileri SA; Inghirami G; Montoto S; Vitolo U; Radford J; Vose JM; Federico M
    Blood; 2021 Jul; 138(3):213-220. PubMed ID: 34292324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features, outcome and prognostic factors of 87 patients with angioimmunoblastic T cell lymphoma in Taiwan.
    Kao HW; Lin TL; Shih LY; Dunn P; Kuo MC; Hung YS; Wu JH; Tang TC; Chang H; Kuo TT; Ou CW; Wang PN
    Int J Hematol; 2016 Aug; 104(2):256-65. PubMed ID: 27095042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics of angioimmunoblastic T-cell lymphoma in China and C-reactive protein as an independent prognostic factor.
    Li Y; Yang C; Mao L; Wang J; Li C; Qian W
    Medicine (Baltimore); 2017 Sep; 96(39):e8091. PubMed ID: 28953629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic characteristics, outcomes, and prognostic factors of angioimmunoblastic T-cell lymphoma in China.
    Wei C; Li W; Qin L; Liu S; Xue C; Ren K; Zhang Z; Liu C; Bao F; Zhang H; Zhou H; Li Z; Wu H; Zou L; Liu L; Jing H; Zhang W
    Cancer Med; 2023 Feb; 12(4):3987-3998. PubMed ID: 36106610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angioimmunoblastic T-cell lymphoma: a prognostic model from a retrospective study.
    Hong H; Fang X; Wang Z; Huang H; Lam ST; Li F; Peng C; Tian Y; Lin S; Lin T
    Leuk Lymphoma; 2018 Dec; 59(12):2911-2916. PubMed ID: 29909754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of stem cell transplantation in patients with peripheral T-cell lymphoma not otherwise specified and angioimmunoblastic T-cell lymphoma.
    Yamasaki S; Yoshida S; Kato K; Choi I; Imamura Y; Kohno K; Henzan H; Tanimoto K; Ogawa R; Suehiro Y; Miyamoto T; Eto T; Ohshima K; Akashi K; Iwasaki H;
    Int J Hematol; 2020 Jul; 112(1):74-83. PubMed ID: 32297159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of autologous stem cell transplantation in patients with nodal peripheral T-cell lymphomas in first complete remission: Report from COMPLETE, a prospective, multicenter cohort study.
    Park SI; Horwitz SM; Foss FM; Pinter-Brown LC; Carson KR; Rosen ST; Pro B; Hsi ED; Federico M; Gisselbrecht C; Schwartz M; Bellm LA; Acosta M; Advani RH; Feldman T; Lechowicz MJ; Smith SM; Lansigan F; Tulpule A; Craig MD; Greer JP; Kahl BS; Leach JW; Morganstein N; Casulo C; Shustov AR;
    Cancer; 2019 May; 125(9):1507-1517. PubMed ID: 30694529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective analysis of prognostic factors for angioimmunoblastic T-cell lymphoma: a multicenter cooperative study in Japan.
    Tokunaga T; Shimada K; Yamamoto K; Chihara D; Ichihashi T; Oshima R; Tanimoto M; Iwasaki T; Isoda A; Sakai A; Kobayashi H; Kitamura K; Matsue K; Taniwaki M; Tamashima S; Saburi Y; Masunari T; Naoe T; Nakamura S; Kinoshita T
    Blood; 2012 Mar; 119(12):2837-43. PubMed ID: 22308294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a Novel Clinical Prognostic Model for Patients With Angioimmunoblastic T-Cell Lymphoma.
    Huang C; Zhang H; Gao Y; Diao L; Liu L
    Technol Cancer Res Treat; 2020; 19():1533033820964231. PubMed ID: 33073702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical characteristics and prognosis in 84 patients with angioimmunoblastic T-cell lymphoma: a single-center analysis].
    Li TT; Luo LT; Chen Y; Yang T; Hu JD
    Zhonghua Xue Ye Xue Za Zhi; 2020 Nov; 41(11):915-920. PubMed ID: 33333694
    [No Abstract]   [Full Text] [Related]  

  • 13. Recent Advances in Diagnosis and Therapy of Angioimmunoblastic T Cell Lymphoma.
    Mohammed Saleh MF; Kotb A; Abdallah GEM; Muhsen IN; El Fakih R; Aljurf M
    Curr Oncol; 2021 Dec; 28(6):5480-5498. PubMed ID: 34940095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel prognostic model for angioimmunoblastic T-cell lymphoma: A retrospective study of 55 cases.
    Sun J; He S; Cen H; Zhou D; Li Z; Wang MY; Ke Q; Guo BP; Liao CC; Rong C; Zhong DN; Tan XH
    J Int Med Res; 2021 May; 49(5):3000605211013274. PubMed ID: 34034561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of prognostic scores in transplant-ineligible patients with peripheral T-cell lymphoma not otherwise specified and angioimmunoblastic T-cell lymphoma: a retrospective study from the national hospital organization in Japan.
    Yamasaki S; Iida H; Yoshida I; Komeno T; Sawamura M; Matsumoto M; Sekiguchi N; Hishita T; Sunami K; Shimomura T; Takatsuki H; Yoshida S; Otsuka M; Kato T; Kuroda Y; Ooyama T; Suzuki Y; Ohshima K; Nagai H; Iwasaki H
    Leuk Lymphoma; 2021 Apr; 62(4):819-827. PubMed ID: 33167741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of combined modality treatment in first-line for stage I(E) peripheral T-cell lymphoma; a nationwide population-based cohort study from the Netherlands.
    Meeuwes FO; Brink M; Plattel W; Van der Poel MWM; Kersten MJ; Wondergem M; Böhmer L; Woei-A-Jin FJSH; Visser O; Oostvogels R; Jansen PM; Neelis KJ; Crijns APG; Daniëls LA; Snijders TJF; Vermaat JSP; Huls GA; Nijland M
    Haematologica; 2024 Apr; 109(4):1163-1170. PubMed ID: 37794805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project.
    Federico M; Rudiger T; Bellei M; Nathwani BN; Luminari S; Coiffier B; Harris NL; Jaffe ES; Pileri SA; Savage KJ; Weisenburger DD; Armitage JO; Mounier N; Vose JM
    J Clin Oncol; 2013 Jan; 31(2):240-6. PubMed ID: 22869878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical analysis of 12 patients with angioimmunoblastic T cell lymphoma].
    Wang SH; Wang QS; Sun L; Li HH; Zhao Y; Jia BJ; Zhang XL; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1208-10. PubMed ID: 21129262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic and prognostic implications of tumor expression of the GATA-3 gene in nodal peripheral T-cell lymphoma (nPTCL): Retrospective data from a Latin American cohort.
    de Pádua Covas Lage LA; Brito CV; Levy D; Culler HF; Freitas Couto SC; de Oliveira LBA; Nogueira Zerbini MC; Rocha V; Pereira J
    Leuk Res; 2022 Mar; 114():106794. PubMed ID: 35131666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral T-cell lymphoma with a T follicular-helper phenotype: A different entity? Results of the Spanish Real-T study.
    Martín García-Sancho A; Rodríguez-Pinilla SM; Domingo-Domenech E; Climent F; Sánchez-Garcia J; López Jiménez J; García-Cosío Piqueras M; Castellvi J; González AJ; González de Villambrosia S; Gómez Codina J; Navarro B; Rodríguez G; Borrero JJ; Fraga M; Naves A; Baeza L; Córdoba R
    Br J Haematol; 2023 Oct; 203(2):182-193. PubMed ID: 37386897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.